Subscribe to Newsletter

Content by Stephanie Vine:

Business & Regulation Business Practice

A Contentious Issue

| Stephanie Vine | 4 min read

Lawsuit from GenBioPro is the first of its kind – but other cases are likely to follow.

Business & Regulation COVID-19

COVID-19: Anti-Vaccine Activists Sue Media Outlets

| Stephanie Vine | 3 min read

Anti-vaccine activists are suing a number of prominent media outlets, including Reuters, the Washington Post, the BBC, and the Associated Press.

Business & Regulation Business Practice

Diversity Matters

| Stephanie Vine | 4 min read

It’s a fact that the pharma industry is dominated by white men. What does this mean for people from different ethnic backgrounds?

Business & Regulation Business Practice

Four Firm Favorites

| Stephanie Vine | 4 min read

From video games to climate change; looking back on a handful of articles from 2022.

Business & Regulation Profession

Words from the Wise

| Stephanie Vine | 2 min read

Five quotes to end the year in style – and thoughtfulness.

Business & Regulation Profession

Driven by Curiosity

| Stephanie Vine | 6 min read

Sitting Down With… Tunde Bello, Vice President of Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb, New Jersey, USA.

Manufacture Small Molecules

Fighting the Resistance – to Malaria

| Stephanie Vine | 4 min read

Widely-used antimalarial drugs are losing efficacy. What are researchers doing to prevent that?

Discovery & Development Formulation

Goodbye, Moisture. Hello, mRNA

| Stephanie Vine | 2 min read

Could dry vaccines help improve global access to the latest vaccine technologies?

Business & Regulation Business Practice

Imposter Twitter Account Loses Eli Lilly Billions

| Stephanie Vine | 2 min read

Fake tweet announcing free insulin leads to mayhem.

Business & Regulation Standards & Regulation

Data Discussions

| Stephanie Vine | 2 min read

How a new working group plans to overcome the problem with in vitro pharmacology data.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register